Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults

South African Medical Journal

Volumn 97, Issue 7, 2007, Pages 517-523

  Saranchuk, P ^a   Boulle, A ^b   Hilderbrand, K ^a   Coetzee, D ^b   Bedelu, M ^a   van Cutsem, G ^a   Meintjes, G ^b,c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c GF Jooste Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; HEMOGLOBIN; METRONIDAZOLE; TUBERCULOSTATIC AGENT;

ADULT; ALGORITHM; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; COUGHING; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG WITHDRAWAL; FATALITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SPUTUM ANALYSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ALGORITHMS; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 34447626839     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
2. Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 1995; 345: 607-610.
3. Corbett EL, Charalambous S, Moloi VM, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170: 673-679.
4. Harries AD, Hargreaves NJ, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357: 1519-1523.
5. Rana FS, Hawken MP, Mwachari C, et al. Autopsy study of HIV-l-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000; 24: 23-29.
6. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993; 7: 1569-1579.
7. Klein NC, Duncanson FP, Lenox TH 3rd, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 1989; 95: 1190-1192.
8. Elliott AM, Namaambo K, Allen BW, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuberc Lung Dis 1993; 74: 191-194.
9. Nunn P, Mungai M, Nyamwaya J, et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuberc Lung Dis 1994; 75: 25-32.
10. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 2003; 3: 288-296.
11. Barnes PF, Bloch AB, Davidson PT, Snider DE jun. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
12. Hudson CP, Wood R, Maartens G. Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay. Int J Tuberc Lung Dis 2000; 4: 240-245.
13. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewen PC. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136: 570-574.
14. Lawn SD, Griffin GE. The irreversible cost of delayed diagnosis of tuberculosis in HIV coinfected persons in sub-Saharan Africa. Int J Tuberc Lung Dis 2001; 5: 200-201.
15. Parry CM, Kamoto O, Harries AD, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuberc Lung Dis 1995; 76: 72-76.
16. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4: 97-107.
17. Stop TB, World Health Organization. An expanded DOTS framework for effective tuberculosis control. Int J Tuberc Lung Dis 2002; 6: 378-388.
18. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis 2006; 10: 31-38.
19. Hargreaves NJ, Kadzakumanja O, Phiri S, et al. What causes smear-negative pulmonary tuberculosis in Malawian area of high HIV seroprevalence? Int J Tuberc Lung Dis 2001; 5: 113-122.
20. Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis 2002; 34: 1607-1612.
21. Ginsburg AS, Hooper N, Parrish N, et al. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis 2003; 37: 1448-1452.